Gene · 5608
Papers2,492
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
321 to 340 of 2,492
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Singlet Oxygen, Photodynamic Therapy, and Mechanisms of Cancer Cell Death. | J Oncol | 2022 | 35794980 | PubTator, text mining | PubMed |
| The role of interleukin‑7 serum level as biological marker in breast cancer: a cross‑sectional, observational, and analytical study. | World J Surg Oncol | 2022 | 35794603 | PubTator, text mining | PubMed |
| CRISPR/Cas9-mediated LINC00511 knockout strategies, increased apoptosis of breast cancer cells via suppressing antiapoptotic genes. | Biol Proced Online | 2022 | 35790898 | PubTator, text mining | PubMed |
| Allosteric inhibition of PPM1D serine/threonine phosphatase via an altered conformational state. | Nat Commun | 2022 | 35773251 | PubTator, text mining | PubMed |
| Kinome profiling of cholangiocarcinoma organoids reveals potential druggable targets that hold promise for treatment stratification. | Mol Med | 2022 | 35764936 | PubTator, text mining | PubMed |
| Senescence: Pathogenic Driver in Chronic Obstructive Pulmonary Disease. | Medicina (Kaunas) | 2022 | 35744080 | PubTator, text mining | PubMed |
| Immune Cell Networks Uncover Candidate Biomarkers of Melanoma Immunotherapy Response. | J Pers Med | 2022 | 35743743 | PubTator, text mining | PubMed |
| Synergistic Antiviral Activity of Pamapimod and Pioglitazone against SARS-CoV-2 and Its Variants of Concern. | Int J Mol Sci | 2022 | 35743273 | PubTator, text mining | PubMed |
| VEGF Pathway Gene Expression Profile of Proliferating versus Involuting Infantile Hemangiomas: Preliminary Evidence and Review of the Literature. | Children (Basel) | 2022 | 35740845 | PubTator, text mining | PubMed |
| Molecular Pathophysiological Mechanisms in Huntington's Disease. | Biomedicines | 2022 | 35740453 | PubTator, text mining | PubMed |
| Comparison of Transcriptional Signatures of Three Staphylococcal Superantigenic Toxins in Human Melanocytes. | Biomedicines | 2022 | 35740423 | PubTator, text mining | PubMed |
| Comprehensive Analysis of Senescence Characteristics Defines a Novel Prognostic Signature to Guide Personalized Treatment for Clear Cell Renal Cell Carcinoma. | Front Immunol | 2022 | 35720278 | PubTator, text mining | PubMed |
| Advances in Immunosuppressive Agents Based on Signal Pathway. | Front Pharmacol | 2022 | 35694243 | PubTator, text mining | PubMed |
| Identification of Crucial lncRNAs for Luminal A Breast Cancer through RNA Sequencing. | Int J Endocrinol | 2022 | 35692369 | PubTator, text mining | PubMed |
| 4-phenylpyridine suppresses UVB-induced skin inflammation by targeting c-Src in vitro and in vivo. | J Cell Mol Med | 2022 | 35686492 | PubTator, text mining | PubMed |
| Anti-Inflammatory Mechanism of An Alkaloid Rutaecarpine in LTA-Stimulated RAW 264.7 Cells: Pivotal Role on NF-κB and ERK/p38 Signaling Molecules. | Int J Mol Sci | 2022 | 35682568 | PubTator, text mining | PubMed |
| Comparative Analysis of Gene Expression Patterns for Oral Epithelial Cell Functions in Periodontitis. | Front Oral Health | 2022 | 35677025 | PubTator, text mining | PubMed |
| Synergistic anti-proliferative activity of JQ1 and GSK2801 in triple-negative breast cancer. | BMC Cancer | 2022 | 35672711 | PubTator, text mining | PubMed |
| Structural and Functional Properties of Activator Protein-1 in Cancer and Inflammation. | Evid Based Complement Alternat Med | 2022 | 35664945 | PubTator, text mining | PubMed |
| Molecular signaling pathways, pathophysiological features in various organs, and treatment strategies in SARS-CoV2 infection. | Acta Histochem | 2022 | 35662001 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5608/papers?page=17